NeurAxis

Carmel, United States

NeurAxis develops neuromodulation therapies to address chronic and debilitating conditions in children.

$2.8M raised

Oct 2025

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NeurAxis raised?

NeurAxis has raised $2.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.

Who are NeurAxis's investors?

NeurAxis's investors include Flagstaff International.

Where is NeurAxis headquartered?

NeurAxis is headquartered in Carmel, United States.

What does NeurAxis do?

NeurAxis develops neuromodulation therapies to address chronic and debilitating conditions in children.

What stage is NeurAxis at?

NeurAxis is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 1, 2025.

MLA

"NeurAxis — Funding & Investors." VCBacked, October 1, 2025, https://www.vcbacked.co/company/neuraxis. Accessed July 2, 2026.

APA

VCBacked. (2025). NeurAxis — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/neuraxis

Wikipedia (cite web)

{{cite web |title=NeurAxis — Funding & Investors |url=https://www.vcbacked.co/company/neuraxis |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 1, 2025.